Health and lifestyle features.
The International Light Association (ILA) is delighted to announce at their conference in September this year, the inception of an annual International Light Day (ILD) the first of which will be celebrated on 22 September 2013, the autumn equinox. The ILA is dedicated to the exploration of the profound effects of light on our health […]
Continue ReadingAccording to a new report by Diabetes UK, test strips are being denied or rationed by the NHS to save money. In response to this, a new website has been launched that offers low priced glucose test strips to enable patients to continue their regular testing. National Diagnostic Products, the Australian manufacturer of Betachek, today […]
Continue ReadingThe launch event at Coin Street Neighbourhood Centre, London, brought together healthcare leaders from CCGs and CSUs, all keen to adopt outcomes based commissioning for their populations. Bob Ricketts’s opening address called for a much-needed transformation in the commissioning landscape. Bob Ricketts CBE, Director of Commissioning Support Services Strategy for NHS England, speaking at the […]
Continue ReadingThe International Light Association (ILA) is dedicated to the exploration of the profound effects of light on our health and wellbeing. The ILA features an international membership, encompassing light therapy practitioners, health professionals, artists, architects, scientists, educators, product manufacturers, interior and exterior designers and philosophers – and welcomes one and all, both those with an […]
Continue ReadingAdult patients in England and Wales to gain access to first-in-class Type 2 diabetes treatment. The National Institute for Health and Care Excellence (NICE) today issued a Final Appraisal Determination (FAD) for Bristol-Myers Squibb and AstraZeneca’s, first-in-class Type 2 diabetes medicine FORXIGA® (dapagliflozin). NICE recommends the use of dapagliflozin as a treatment option for adults […]
Continue ReadingUNITAID’s approach to transform health product markets has delivered price reductions of up to 80% for HIV/AIDS, tuberculosis and malaria medicines and diagnostics for the world’s poor, according to Results Beyond Investment, its 2012 Annual Report just released. As global health funding stagnates, the report shows how the proceeds from UNITAID’s main funding source – […]
Continue ReadingSelon UNITAID, après d’importants résultats obtenus dans la lutte contre le paludisme ces dix dernières années, l’action à venir doit être encore mieux ciblée pour que ces progrès soient maintenus. D’après l’Organisation mondiale de la Santé (OMS), 1,1 million de décès et 274 millions de cas de paludisme ont été évités entre 2001 et 2010 […]
Continue ReadingFollowing the significant gains in the fight against malaria over the past decade, future efforts must be more targeted if progress is to be maintained, UNITAID warns. According to the World Health Organization (WHO), between 2001 and 2010, 1.1 million deaths and 274 million cases of malaria were averted thanks to the scale-up of global […]
Continue ReadingBoulder Diagnostics Inc. announced today the European market launch of its ParaFlor™ kits for the detection of Giardia, Cryptosporidium and Blastocystis infections for human and veterinary applications. The rapid assays enable detection in less than ten minutes in both fresh and fixed stool samples and are also available for veterinary applications and Research Use Only […]
Continue ReadingUp to £190 million of savings could potentially be made to the UK’s health and social care costs without compromising services to service users, according to a leading firm of consultants. Andrew MacGlashan Commercial & Clinical Solutions LLP has worked with over 20 local authorities and health trusts since 2008 to achieve repeat savings of […]
Continue Reading
